{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:55:18Z","timestamp":1785660918574,"version":"3.56.0"},"reference-count":195,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,6,22]]},"DOI":"10.3233\/jad-160169","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T18:44:31Z","timestamp":1466707471000},"page":"15-29","source":"Crossref","is-referenced-by-count":60,"title":["Alzheimer\u2019s Disease Risk Genes and Lipid Regulators"],"prefix":"10.1177","volume":"53","author":[{"given":"Farida","family":"El Gaamouch","sequence":"first","affiliation":[{"name":"James J Peters VA Medical Center, Research & Development, Bronx, NY, USA"},{"name":"Department of Neurology, Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jing","sequence":"additional","affiliation":[{"name":"The Central Hospital of Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Xia","sequence":"additional","affiliation":[{"name":"The Central Hospital of Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Cai","sequence":"additional","affiliation":[{"name":"James J Peters VA Medical Center, Research & Development, Bronx, NY, USA"},{"name":"Department of Neurology, Alzheimer Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA"},{"name":"The Central Hospital of Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160169_ref1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.3233\/JAD-160169_ref2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng1009-1047","article-title":"Alzheimer\u2019s disease beyond APOE","volume":"41","author":"van Es","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-160169_ref3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bcp.2013.12.028","article-title":"Is synaptic loss a unique hallmark of Alzheimer\u2019s disease?","volume":"88","author":"Scheff","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-160169_ref4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00702-006-0592-5","article-title":"Alois Alzheimer revisited: Differences in origin of the disease carrying his name","volume":"113","author":"Maurer","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-160169_ref5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-160169_ref6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JAD-2006-9S340","article-title":"On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease","volume":"9","author":"Roses","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3233\/JAD-160169_ref8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.3233\/JAD-160169_ref9","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.1510011112","article-title":"Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer\u2019s disease pathogenesis","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref10","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1073\/pnas.97.7.3254","article-title":"Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast","volume":"97","author":"Bagnat","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref11","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","article-title":"Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"24","author":"Kawarabayashi","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-160169_ref13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","article-title":"Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Fagan","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160169_ref14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/JMN:17:2:147","article-title":"Role of apoe\/Abeta interactions in the pathogenesis of Alzheimer\u2019s disease and cerebral amyloid angiopathy","volume":"17","author":"Holtzman","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-160169_ref15","doi-asserted-by":"crossref","first-page":"22987","DOI":"10.1074\/jbc.272.37.22987","article-title":"Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles","volume":"272","author":"Choo-Smith","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-5793(96)01504-9","article-title":"The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes","volume":"402","author":"Choo-Smith","year":"1997","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-160169_ref17","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0861-04.2004","article-title":"A seed for Alzheimer amyloid in the brain","volume":"24","author":"Hayashi","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref18","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1021\/bi0255874","article-title":"Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid","volume":"41","author":"Kakio","year":"2002","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160169_ref19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","article-title":"Soluble Abeta oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes","volume":"82","author":"Hong","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-160169_ref20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/jz500054d","article-title":"Membrane-protein interactions are key to understanding amyloid formation","volume":"5","author":"Straub","year":"2014","journal-title":"J Phys Chem Lett"},{"key":"10.3233\/JAD-160169_ref21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/jz4024354","article-title":"Amyloid aggregation: Role of biological membranes and the aggregate-membrane system","volume":"5","author":"Bucciantini","year":"2014","journal-title":"J Phys Chem Lett"},{"key":"10.3233\/JAD-160169_ref22","doi-asserted-by":"crossref","first-page":"24985","DOI":"10.1074\/jbc.M100252200","article-title":"Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid","volume":"276","author":"Kakio","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref23","doi-asserted-by":"crossref","first-page":"26482","DOI":"10.1074\/jbc.271.43.26482","article-title":"Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity","volume":"271","author":"McLaurin","year":"1996","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/tx9601317","article-title":"Disruption of brain cell ion homeostasis in Alzheimer\u2019s disease by oxy radicals, and signaling pathways that protect therefrom","volume":"10","author":"Mattson","year":"1997","journal-title":"Chem Res Toxicol"},{"key":"10.3233\/JAD-160169_ref25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0006-3495(01)76109-7","article-title":"Amyloid-beta peptide assembly: A critical step in fibrillogenesis and membrane disruption","volume":"80","author":"Yip","year":"2001","journal-title":"Biophys J"},{"key":"10.3233\/JAD-160169_ref26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jmb.2008.07.072","article-title":"Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: Polymorphisms in Abeta(1-40) fibrils","volume":"382","author":"Okada","year":"2008","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-160169_ref27","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.bbamem.2006.12.014","article-title":"Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins","volume":"1768","author":"Murphy","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160169_ref28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/bbrc.1995.1174","article-title":"Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates","volume":"207","author":"Good","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-160169_ref29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-022X(03)00103-9","article-title":"Kinetics of adsorption of beta-amyloid peptide Abeta(1-40) to lipid bilayers","volume":"57","author":"Kremer","year":"2003","journal-title":"J Biochem Biophys Methods"},{"key":"10.3233\/JAD-160169_ref30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/BC20060051","article-title":"Lipid rafts in health and disease","volume":"99","author":"Michel","year":"2007","journal-title":"Biol Cell"},{"key":"10.3233\/JAD-160169_ref31","doi-asserted-by":"crossref","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3593-07.2007","article-title":"Omega-3 fatty acid docosahexaenoic acid increases SorLA\/LR11, a sorting protein with reduced expression in sporadic Alzheimer\u2019s disease (AD): Relevance to AD prevention","volume":"27","author":"Ma","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainresbull.2010.02.013","article-title":"Lipid rafts: Keys to neurodegeneration","volume":"82","author":"Schengrund","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-160169_ref33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1126\/science.1156609","article-title":"Efficient inhibition of the Alzheimer\u2019s disease beta-secretase by membrane targeting","volume":"320","author":"Rajendran","year":"2008","journal-title":"Science"},{"key":"10.3233\/JAD-160169_ref34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CIA.S5231","article-title":"Omega-3 fatty acids: Potential role in the management of early Alzheimer\u2019s disease","volume":"5","author":"Jicha","year":"2010","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-160169_ref35","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","article-title":"Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms","volume":"286","author":"Grimm","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-2010-1242","article-title":"Lipid alterations in lipid rafts from Alzheimer\u2019s disease human brain cortex","volume":"19","author":"Martin","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2012.06.053","article-title":"Lipid rafts, synaptic transmission and plasticity: Impact in age-related neurodegenerative diseases","volume":"64","author":"Sebastiao","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-160169_ref38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.1998.9652","article-title":"Elevated low-density lipoprotein in Alzheimer\u2019s disease correlates with brain abeta 1-42 levels","volume":"252","author":"Kuo","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-160169_ref39","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: Longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.3233\/JAD-160169_ref40","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"issue":"Suppl 2","key":"10.3233\/JAD-160169_ref41","first-page":"S107","article-title":"Cholesterol, synaptic function and Alzheimer\u2019s disease","volume":"36","author":"Koudinov","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.3233\/JAD-160169_ref42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1471-4159.2001.00063.x","article-title":"Cholesterol-dependent modulation of tau phosphorylation in cultured neurons","volume":"76","author":"Fan","year":"2001","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jnr.10348","article-title":"Cholesterol and pathological processes in Alzheimer\u2019s disease","volume":"70","author":"Yanagisawa","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-160169_ref44","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1083\/jcb.200404149","article-title":"Neuronal membrane cholesterol loss enhances amyloid peptide generation","volume":"167","author":"Abad-Rodriguez","year":"2004","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-160169_ref45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00023210-200216070-00001","article-title":"Hypertension and hypercholesterolaemia as risk factors for Alzheimer\u2019s disease: Potential for pharmacological intervention","volume":"16","author":"Kivipelto","year":"2002","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-160169_ref46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0197-4580(02)00018-0","article-title":"Brain membrane cholesterol domains, aging and amyloid beta-peptides","volume":"23","author":"Wood","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160169_ref47","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2007.10.005","article-title":"Cholesterol retention in Alzheimer\u2019s brain is responsible for high beta- and gamma-secretase activities and Abeta production","volume":"29","author":"Xiong","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160169_ref49","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1096\/fj.10-168633","article-title":"Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis","volume":"25","author":"Marquer","year":"2011","journal-title":"FASEB J"},{"key":"10.3233\/JAD-160169_ref51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"key":"10.3233\/JAD-160169_ref52","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2009.06126.x","article-title":"Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface","volume":"110","author":"Guardia-Laguarta","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref54","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/pro.678","article-title":"Lipid composition influences the release of Alzheimer\u2019s amyloid beta-peptide from membranes","volume":"20","author":"Lemkul","year":"2011","journal-title":"Protein Sci"},{"key":"10.3233\/JAD-160169_ref55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jmb.2011.11.006","article-title":"Cholesterol promotes the interaction of Alzheimer beta-amyloid monomer with lipid bilayer","volume":"421","author":"Yu","year":"2012","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-160169_ref56","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.bpj.2009.02.036","article-title":"Cholesterol modulates the interaction of beta-amyloid peptide with lipid bilayers","volume":"96","author":"Qiu","year":"2009","journal-title":"Biophys J"},{"key":"10.3233\/JAD-160169_ref57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000017234","article-title":"Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: Specific changes in Alzheimer\u2019s disease","volume":"11","author":"Eckert","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-160169_ref58","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1385\/JMN:20:3:395","article-title":"Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol","volume":"20","author":"Petanceska","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-160169_ref59","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00702-002-0809-1","article-title":"Brain region-dependent increases in beta-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits","volume":"110","author":"Wu","year":"2003","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-160169_ref60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160169_ref61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00001756-200203250-00019","article-title":"Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice","volume":"13","author":"Shie","year":"2002","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-160169_ref62","first-page":"268","article-title":"Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation","volume":"37","author":"Sing","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-160169_ref63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer\u2019s disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-160169_ref64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1306.005","article-title":"Iron, atherosclerosis, and neurodegeneration: A key role for cholesterol in promoting iron-dependent oxidative damage?","volume":"1012","author":"Ong","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-160169_ref65","doi-asserted-by":"crossref","first-page":"19524","DOI":"10.1073\/pnas.0604954103","article-title":"Presenilin mutations linked to familial Alzheimer\u2019s disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism","volume":"103","author":"Landman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nn.2100","article-title":"Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism","volume":"11","author":"Berman","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160169_ref67","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/nn.2213","article-title":"Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Sanchez-Mejia","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160169_ref68","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1471-4159.1987.tb05619.x","article-title":"Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains","volume":"48","author":"Stokes","year":"1987","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref69","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1073\/pnas.89.5.1671","article-title":"Evidence for a membrane defect in Alzheimer disease brain","volume":"89","author":"Nitsch","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1023\/A:1011603916962","article-title":"Brain membrane phospholipid alterations in Alzheimer\u2019s disease","volume":"26","author":"Pettegrew","year":"2001","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-160169_ref71","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"10.3233\/JAD-160169_ref72","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.3233\/JAD-160169_ref73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","author":"Di Paolo","year":"2006","journal-title":"Nature"},{"key":"10.3233\/JAD-160169_ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2004.09.019","article-title":"Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior","volume":"159","author":"Grootendorst","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-160169_ref75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-4-21","article-title":"ApoE isoform-dependent changes in hippocampal synaptic function","volume":"4","author":"Korwek","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-160169_ref76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00223534","article-title":"Apolipoprotein E","volume":"42","author":"Zannis","year":"1982","journal-title":"Mol Cell Biochem"},{"key":"10.3233\/JAD-160169_ref77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1582-4934.2001.tb00159.x","article-title":"Apolipoprotein E: A major piece in the Alzheimer\u2019s disease puzzle","volume":"5","author":"Cedazo-Minguez","year":"2001","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-160169_ref78","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"Phillips","year":"2014","journal-title":"IUBMB Life"},{"key":"10.3233\/JAD-160169_ref79","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: Genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-160169_ref80","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archneur.55.8.1065","article-title":"Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia","volume":"55","author":"Jonker","year":"1998","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160169_ref81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/1206","article-title":"APOE genotype predicts when\u2013not whether\u2013one is predisposed to develop Alzheimer disease","volume":"19","author":"Meyer","year":"1998","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-160169_ref82","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160169_ref83","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.3233\/JAD-160169_ref84","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160169_ref85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.3233\/JAD-160169_ref86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: Structure-function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv Protein Chem"},{"key":"10.3233\/JAD-160169_ref87","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.STR.27.12.2230","article-title":"Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men","volume":"27","author":"Kalmijn","year":"1996","journal-title":"Stroke"},{"key":"10.3233\/JAD-160169_ref88","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160169_ref89","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/WNL.50.6.1580","article-title":"Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins","volume":"50","author":"Carmelli","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-160169_ref90","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.282.1.40","article-title":"The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons","volume":"282","author":"Haan","year":"1999","journal-title":"JAMA"},{"key":"10.3233\/JAD-160169_ref91","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.3233\/JAD-160169_ref92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneur.60.1.29","article-title":"Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism","volume":"60","author":"Papassotiropoulos","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160169_ref93","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1023\/A:1026017206925","article-title":"Plasticity and the spread of Alzheimer\u2019s disease-like changes","volume":"28","author":"Ohm","year":"2003","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-160169_ref94","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.mp.4001296","article-title":"Genetic association of acyl-coenzyme A: Cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer\u2019s disease","volume":"8","author":"Wollmer","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-160169_ref95","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat Med"},{"key":"10.3233\/JAD-160169_ref96","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref97","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","article-title":"Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease","volume":"33","author":"Bertrand","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-160169_ref98","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bies.10236","article-title":"Alzheimer vaccine: Amyloid-beta on trial","volume":"25","author":"Robinson","year":"2003","journal-title":"Bioessays"},{"key":"10.3233\/JAD-160169_ref99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-8981(97)00207-6","article-title":"Alzheimer\u2019s amyloid beta interaction with normal human plasma high density lipoprotein: Association with aolipoprotein and lipids","volume":"270","author":"Koudinov","year":"1998","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-160169_ref100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(01)02263-7","article-title":"The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer\u2019s and normal aging cerebrospinal fluid: Implication for brain cholesterol pathology?","volume":"314","author":"Koudinov","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160169_ref101","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1073\/pnas.0404458101","article-title":"A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade","volume":"101","author":"Dolev","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref102","doi-asserted-by":"crossref","first-page":".339","DOI":"10.1124\/mi.2.6.363","article-title":"Apolipoprotein E, amyloid, and Alzheimer disease","volume":"2","author":"Bales","year":"2002","journal-title":"Mol Interv"},{"key":"10.3233\/JAD-160169_ref103","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H","article-title":"Association of human, rat, and rabbit apolipoprotein E with beta-amyloid","volume":"49","author":"LaDu","year":"1997","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-160169_ref105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/1097-0029(20000815)50:4<316::AID-JEMT11>3.0.CO;2-E","article-title":"Influence of lipoproteins on microglial degradation of Alzheimer\u2019s amyloid beta-protein","volume":"50","author":"Cole","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.3233\/JAD-160169_ref106","first-page":"65","article-title":"Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells","volume":"32","author":"Yamauchi","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"10.3233\/JAD-160169_ref107","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-160169_ref108","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2174\/138161208784705487","article-title":"The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer\u2019s disease","volume":"14","author":"Deane","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-160169_ref109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1385\/MN:23:1:53","article-title":"Low-density lipoprotein receptor family: Endocytosis and signal transduction","volume":"23","author":"Li","year":"2001","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160169_ref110","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160169_ref111","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nurt.2008.05.011","article-title":"New therapeutic targets in the neurovascular pathway in Alzheimer\u2019s disease","volume":"5","author":"Zlokovic","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-160169_ref112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160169_ref113","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","article-title":"Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid","volume":"270","author":"LaDu","year":"1995","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"10.3233\/JAD-160169_ref114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem J"},{"key":"10.3233\/JAD-160169_ref115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","article-title":"Apolipoprotein E associates with beta amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3","volume":"94","author":"Sanan","year":"1994","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160169_ref116","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/bi982437d","article-title":"Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations","volume":"38","author":"Moir","year":"1999","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160169_ref117","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.05099.x","article-title":"Role of ATP-binding cassette transporters in brain lipid transport and neurological disease","volume":"104","author":"Kim","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref118","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref119","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M300044200","article-title":"22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion","volume":"278","author":"Koldamova","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/humu.20012","article-title":"Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism","volume":"23","author":"Katzov","year":"2004","journal-title":"Hum Mutat"},{"key":"10.3233\/JAD-160169_ref121","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref122","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref123","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dmrr.895","article-title":"Cellular cholesterol efflux to serum is impaired in diabetic nephropathy","volume":"24","author":"Zhou","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.3233\/JAD-160169_ref124","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-2011-110521","article-title":"Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-beta production independent of cholesterol efflux activity","volume":"27","author":"Kim","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.3233\/JAD-160169_ref126","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref127","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-160169_ref128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5551\/jat.6726","article-title":"Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system","volume":"18","author":"Tanaka","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"10.3233\/JAD-160169_ref129","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.ATV.0000075912.83860.26","article-title":"Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux","volume":"23","author":"Wang","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-160169_ref130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1074\/jbc.M309888200","article-title":"Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein","volume":"279","author":"Abe-Dohmae","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1471-4159.2008.05433.x","article-title":"ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro","volume":"106","author":"Chan","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref132","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1523\/JNEUROSCI.4165-12.2013","article-title":"Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer\u2019s disease","volume":"33","author":"Kim","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref133","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-141320","article-title":"ABCA5 regulates amyloid-beta peptide production and is associated with Alzheimer\u2019s disease neuropathology","volume":"43","author":"Fu","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref134","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1073\/pnas.0510710103","article-title":"Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer\u2019s disease-linked presenilin-1 mutant neurons","volume":"103","author":"Cai","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref135","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1523\/JNEUROSCI.3317-10.2010","article-title":"Phospholipase d2 ablation ameliorates Alzheimer\u2019s disease-linked synaptic dysfunction and cognitive deficits","volume":"30","author":"Oliveira","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref136","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(01)02339-4","article-title":"Enhancement of phospholipase D activity by overexpression of amyloid precursor protein in P19 mouse embryonic carcinoma cells","volume":"315","author":"Lee","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160169_ref137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(97)00407-2","article-title":"Amyloid beta-induced neurotoxicity is associated with phospholipase D activation in cultured rat hippocampal cells","volume":"229","author":"Cox","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160169_ref138","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1074\/jbc.M209065200","article-title":"Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein","volume":"278","author":"Cai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref139","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1073\/pnas.0510708103","article-title":"Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation","volume":"103","author":"Cai","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature12825","article-title":"Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease","volume":"505","author":"Cruchaga","year":"2014","journal-title":"Nature"},{"key":"10.3233\/JAD-160169_ref141","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12035-014-8779-5","article-title":"PLD3 in Alzheimer\u2019s disease","volume":"51","author":"Wang","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160169_ref142","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1038\/nature14039","article-title":"PLD3 in non-familial Alzheimer\u2019s disease","volume":"520","author":"Heilmann","year":"2015","journal-title":"Nature"},{"key":"10.3233\/JAD-160169_ref143","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/humu.22908","article-title":"Rare variants in PLD3 do not affect risk for early-onset Alzheimer disease in a European Consortium Cohort","volume":"36","author":"Cacace","year":"2015","journal-title":"Hum Mutat"},{"key":"10.3233\/JAD-160169_ref144","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A mitochondrial cascade hypothesis for sporadic Alzheimer\u2019s disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med Hypotheses"},{"issue":"Suppl 2","key":"10.3233\/JAD-160169_ref145","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref146","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bbabio.2012.04.015","article-title":"The stability and activity of respiratory Complex II is cardiolipin-dependent","volume":"1817","author":"Schwall","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160169_ref147","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2011.07636.x","article-title":"Tacrine and its analogues impair mitochondrial function and bioenergetics: A lipidomic analysis in rat brain","volume":"120","author":"Melo","year":"2012","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref148","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-4159.2008.05383.x","article-title":"Lipidomic analysis and electron transport chain activities in C57BL\/6J mouse brain mitochondria","volume":"106","author":"Kiebish","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref149","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201006159","article-title":"Making heads or tails of phospholipids in mitochondria","volume":"192","author":"Osman","year":"2011","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-160169_ref150","doi-asserted-by":"crossref","first-page":"43553","DOI":"10.1074\/jbc.C200551200","article-title":"Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref151","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.bbamem.2009.04.020","article-title":"Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function","volume":"1788","author":"Claypool","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160169_ref152","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1152\/ajpcell.00243.2006","article-title":"Role of cardiolipin alterations in mitochondrial dysfunction and disease","volume":"292","author":"Chicco","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.3233\/JAD-160169_ref153","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3233\/JAD-141002","article-title":"Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"43","author":"Monteiro-Cardoso","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref154","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-4157(92)90035-9","article-title":"Cardiolipins and biomembrane function","volume":"1113","author":"Hoch","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160169_ref155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/bi00530a031","article-title":"Specificity and binding affinity of phospholipids to the high-affinity cardiolipin sites of beef heart cytochrome c oxidase","volume":"21","author":"Robinson","year":"1982","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160169_ref156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1988.tb13750.x","article-title":"Identification and primary structure of the cardiolipin-binding domain of mitochondrial creatine kinase","volume":"171","author":"Cheneval","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-160169_ref157","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1210148","article-title":"Mass spectrometry of intact V-type ATPases reveals bound lipids and the effects of nucleotide binding","volume":"334","author":"Zhou","year":"2011","journal-title":"Science"},{"key":"10.3233\/JAD-160169_ref158","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0021-9258(17)42117-X","article-title":"The reconstituted ADP\/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants","volume":"269","author":"Hoffmann","year":"1994","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref159","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nn.3195","article-title":"Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury","volume":"15","author":"Ji","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-160169_ref160","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1016\/j.febslet.2006.10.036","article-title":"Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: Induction of permeability transition and cytochrome c release","volume":"580","author":"Petrosillo","year":"2006","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-160169_ref161","doi-asserted-by":"crossref","first-page":"18797","DOI":"10.1016\/S0021-9258(17)30583-5","article-title":"Mitochondrial contact sites. Lipid composition and dynamics","volume":"265","author":"Ardail","year":"1990","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref162","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.freeradbiomed.2009.03.004","article-title":"Cytochrome c\/cardiolipin relations in mitochondria: A kiss of death","volume":"46","author":"Kagan","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-160169_ref163","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1194\/jlr.M010520","article-title":"Cardiolipin: Characterization of distinct oxidized molecular secies","volume":"52","author":"Kim","year":"2011","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-160169_ref164","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1471-4159.1980.tb07100.x","article-title":"Transient formation of superoxide radicals in polyunsaturated fatty acid-induced brain swelling","volume":"35","author":"Chan","year":"1980","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160169_ref165","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3171\/jns.2000.93.5.0815","article-title":"Impaired cerebral mitochondrial function after traumatic brain injury in humans","volume":"93","author":"Verweij","year":"2000","journal-title":"J Neurosurg"},{"key":"10.3233\/JAD-160169_ref166","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(99)00257-9","article-title":"F(2)-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo","volume":"147","author":"Pratico","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.3233\/JAD-160169_ref168","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tips.2005.10.001","article-title":"Thromboxane, prostacyclin and isoprostanes: Therapeutic targets in atherogenesis","volume":"26","author":"Dogne","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-160169_ref169","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1074\/jbc.M507340200","article-title":"Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases","volume":"281","author":"Stafforini","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M800607-JLR200","article-title":"HDL is the major lipoprotein carrier of plasma F2-isoprostanes","volume":"50","author":"Proudfoot","year":"2009","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-160169_ref171","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratico","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref172","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2005.01.023","article-title":"Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: Implications for clinical trials","volume":"1037","author":"Quinn","year":"2005","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160169_ref173","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1523\/JNEUROSCI.3591-05.2005","article-title":"Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer\u2019s disease","volume":"25","author":"Liang","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref174","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1096\/fj.02-0012fje","article-title":"Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice","volume":"16","author":"Pratico","year":"2002","journal-title":"FASEB J"},{"key":"10.3233\/JAD-160169_ref175","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/CIRCULATIONAHA105.562223","article-title":"Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: Evidence from apolipoprotein E- and LDL receptor-deficient mice","volume":"112","author":"Tang","year":"2005","journal-title":"Circulation"},{"key":"10.3233\/JAD-160169_ref176","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0006-2952(01)00919-4","article-title":"Alzheimer\u2019s disease and oxygen radicals: New insights","volume":"63","author":"Pratico","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-160169_ref177","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.03-0961fje","article-title":"Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer\u2019s disease","volume":"18","author":"Sung","year":"2004","journal-title":"FASEB J"},{"key":"10.3233\/JAD-160169_ref178","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.neurobiolaging.2007.12.013","article-title":"Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer\u2019s mouse model","volume":"30","author":"Karuppagounder","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160169_ref179","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","article-title":"Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice","volume":"100","author":"Bayer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160169_ref180","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1523\/JNEUROSCI.0684-08.2008","article-title":"Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice","volume":"28","author":"Shineman","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-160169_ref181","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0002-9440(10)63968-5","article-title":"Brain regional quantification of F-ring and D-\/E-ring isoprostanes and neuroprostanes in Alzheimer\u2019s disease","volume":"158","author":"Reich","year":"2001","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-160169_ref182","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.410440322","article-title":"Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer\u2019s disease","volume":"44","author":"Montine","year":"1998","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160169_ref183","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1096\/fasebj.12.15.1777","article-title":"Increased F2-isoprostanes in Alzheimer\u2019s disease: Evidence for enhanced lipid peroxidation in vivo","volume":"12","author":"Pratico","year":"1998","journal-title":"FASEB J"},{"key":"10.3233\/JAD-160169_ref184","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-2-2","article-title":"Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease","volume":"2","author":"Casadesus","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-160169_ref185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.20629","article-title":"Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment","volume":"58","author":"Markesbery","year":"2005","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160169_ref186","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-160169_ref187","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1212\/WNL.52.3.562","article-title":"Increased CSF F2-isoprostane concentration in probable AD","volume":"52","author":"Montine","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-160169_ref188","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neurobiolaging.2007.08.010","article-title":"Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment","volume":"30","author":"Brys","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160169_ref189","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.biopsych.2007.05.030","article-title":"Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints","volume":"63","author":"Mosconi","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-160169_ref190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2004-6110","article-title":"Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer\u2019s disease","volume":"6","author":"Quinn","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref191","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s00415-007-0610-z","article-title":"Longitudinal CSF isoprostane and MRI atrophy in the progression to AD","volume":"254","author":"de Leon","year":"2007","journal-title":"J Neurol"},{"key":"10.3233\/JAD-160169_ref192","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neurobiolaging.2007.08.019","article-title":"The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer\u2019s disease","volume":"30","author":"Glodzik-Sobanska","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160169_ref193","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-122227","article-title":"Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE epsilon4 carriers","volume":"36","author":"Duits","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160169_ref194","doi-asserted-by":"crossref","first-page":"13605","DOI":"10.1074\/jbc.273.22.13605","article-title":"Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid","volume":"273","author":"Roberts","year":"1998","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160169_ref195","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/00207454.2014.971787","article-title":"Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer\u2019s disease","volume":"125","author":"Kuo","year":"2015","journal-title":"Int J Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:58Z","timestamp":1777370578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":195,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-160169","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}